Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Alvogen
company
About
Alvogen is an American pharmaceuticals company founded in 2009.
- 251 - 500
Highlights
Details
- Industries
- Health Care,Manufacturing,Medical,Pharmaceutical
- Founded date
- Jan 1, 2009
- Number Of Employee
- 251 - 500
- Operating Status
- Active
Alvogen is an international, privately-owned specialty pharmaceutical company focused on the development, manufacturing, and marketing of generic pharmaceuticals, biosimilar products, and OTC (over-the-counter medicines). Alvogen’s lines of business include generic sales and marketing (Gx), product development, contract manufacturing (CMO), and contract research (CRO).
Investments
Number of Investments
Number of Lead Investments
4
0
Alvogen has made 4 investments. Their most recent investment was on
Feb 1, 2022, when OLIPOP raised $30M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Feb 1, 2022
OLIPOP
|
Series B | $30M | Food and Beverage | — |
|
Oct 4, 2021
Inkitt
|
Series B | $59M | Analytics | — |
|
Oct 27, 2020
Alvotech
|
Series Unknown | $65M | Biotechnology | — |
|
Jan 20, 2016
Citymapper
|
Series B | $40M | Big Data | — |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
